Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 162
Filtrar
1.
J Hosp Infect ; 108: 135-141, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33296706

RESUMEN

BACKGROUND: During manual resuscitation, nebulizer therapy may be used to deliver therapeutics to patients in respiratory distress. However, the devices used to generate and deliver these medical aerosols have the potential to release these therapeutics into the local environment and expose caregivers to unwanted medical aerosols. AIM: To quantify the levels of fugitive medical aerosol released into the environment during aerosol drug delivery using a manual resuscitation bag with and without filtration. METHODS: Time-varying fugitive aerosol concentrations were measured using an aerodynamic particle sizer placed at a position designed to mimic a caregiver. Two nebulizer types were assessed, a vibrating mesh nebulizer and a jet nebulizer. The aerosol dose delivered to the simulated patient lung was also quantified. FINDINGS: Filtration of the exhalation port of the manual resuscitation bag was seen to reduce fugitive medical aerosols to ambient levels for both nebulizer types. The vibrating mesh nebulizer delivered the greatest quantity of aerosol to the simulated adult patient (18.44 ± 1.03% versus 3.64 ± 0.26% with a jet nebulizer). CONCLUSIONS: The results highlight the potential for exposure to fugitive medical aerosols released during the delivery of aerosol therapy with a manual resuscitation bag and also the potential for significant variation in patient lung dose depending on nebulizer type.


Asunto(s)
Aerosoles/análisis , Albuterol/análisis , Broncodilatadores/análisis , Nebulizadores y Vaporizadores/clasificación , Administración por Inhalación , Diseño de Equipo
2.
Spectrochim Acta A Mol Biomol Spectrosc ; 222: 117219, 2019 Nov 05.
Artículo en Inglés | MEDLINE | ID: mdl-31177007

RESUMEN

Spectrophotometric-assisted chemometric techniques are beneficial for resolving spectral overlapping and are considered comparable to traditional chromatographic methods. In this work, different chemometric approaches were applied for simultaneous determination of Bromhexine HCl (BRHX), Guaifenesin (GUA) and Salbutamol sulphate (SALB) in the presence of Guaiacol (GUAIA), without any prior separation. Two-way and three-way techniques were applied. The resolving power of genetic algorithm (GA-PLS), trilinear partial least square (N-PLS) and multivariate curve resolution (MCR-ALS) were investigated. A set of 17 synthetic samples in the concentration range 10.0-30.0 µg/mL of BRHX, GUA and SALB and 6.0-10.0 µg/mL of GUAIA were used in the construction of the calibration models. Commercially available syrup dosage form was successfully analyzed by the developed methods without interference from formulation additives. The developed models were evaluated through calculation of root mean squared error of prediction (RMSEP), the obtained values were 0.263, 0.419 and 0.342 for BRHX, 0.254, 0.318 and 0.503 for GUA and 0.298, 0.268 and 0.302 for SALB using N-PLS, MCR-ALS and GA-PLS, respectively. The resolving power of the developed models was emphasized through comparison with a reported HPLC method, where no significant difference was found regarding both accuracy and precision.


Asunto(s)
Albuterol/análisis , Bromhexina/análisis , Broncodilatadores/análisis , Expectorantes/análisis , Guayacol/análisis , Guaifenesina/análisis , Algoritmos , Análisis de los Mínimos Cuadrados , Análisis Multivariante , Espectrofotometría/métodos
3.
Respir Care ; 64(11): 1366-1370, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31113855

RESUMEN

BACKGROUND: Pediatric patients treated with noninvasive ventilation (NIV) are frequently given aerosol therapy. Limited pediatric data are available on the efficiency of aerosol delivery efficiency. We evaluated the effect of different nebulizers, positions in the single-limb ventilator circuit, and ventilator settings on the efficiency of aerosol delivery in a model of pediatric NIV. We hypothesized that using a vibrating mesh nebulizer, placing the nebulizer after the circuit leak, and not using the highest inspiratory positive airway pressure would increase aerosol delivery efficiency. METHODS: We connected a breathing simulator in series to a low-dead-space filter holder (lung dose) and to an anatomically correct face/airway model of a 5-y-old child. A mask with an entrainment elbow was connected to a ventilator operated in a NIV bi-level mode and assembled with a single-limb heated-wired circuit. Inspiratory/expiratory pressures of either 15/5 or 20/5 cm H2O were used. We studied 3 different jet nebulizers and 2 vibrating mesh nebulizers loaded with albuterol solution (2.5 mg/3 mL). Albuterol was measured with spectrophotometry. The outcome measure was the efficiency of aerosol delivery (ie, lung dose expressed as percentage of the nominal dose). RESULTS: Vibrating mesh nebulizers placed after the exhalation port of the circuit had the highest delivery efficiency, even compared with a vibrating mesh nebulizer integrated into the mask. Placing the nebulizer after the exhalation port of the circuit increased efficiency for all nebulizers. Vibrating mesh nebulizers were more efficient than jet nebulizers, regardless of their position in the circuit. Increasing the inspiratory pressure resulted in a variable effect on aerosol-delivery efficiency. CONCLUSIONS: In a model of pediatric NIV using a single-limb circuit, aerosol delivery devices were more efficient when placed after the exhalation port of the ventilator circuit. Vibrating mesh nebulizers were more efficient than jet nebulizers.


Asunto(s)
Albuterol , Sistemas de Liberación de Medicamentos , Terapia Respiratoria , Albuterol/administración & dosificación , Albuterol/efectos adversos , Albuterol/análisis , Broncodilatadores/administración & dosificación , Broncodilatadores/efectos adversos , Broncodilatadores/análisis , Preescolar , Sistemas de Liberación de Medicamentos/instrumentación , Sistemas de Liberación de Medicamentos/métodos , Humanos , Monitoreo Fisiológico/métodos , Nebulizadores y Vaporizadores/normas , Ventilación no Invasiva/métodos , Evaluación de Procesos y Resultados en Atención de Salud , Proyectos de Investigación , Terapia Respiratoria/instrumentación , Terapia Respiratoria/métodos , Espectrofotometría/métodos , Resultado del Tratamiento
4.
Ann Pharm Fr ; 77(4): 295-301, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31027752

RESUMEN

OBJECTIVE: The objective of the present work was to develop and validate a simple, sensitive, rapid and stable reverse-phase high performance liquid chromatography (RP-HPLC) method for a combination of Terbutaline sulphate (TSL), Ambroxol hydrochloride (AML) and Guaifenesin (GFN). METHOD: The combination of these drugs was analyzed by using Shimadzu LC 2010 CHT high performance liquid chromatography (HPLC). Successful separation was achieved by isocratic elution on a reverse-phase C18 column (sun fire) (250mm, 4.6mm, 5µ), using a mobile phase consisting of buffer: acetonitrile in the ratio 80: 20 (buffer - 0.1% v/v triethyleamine pH-3.0) followed by 1.0mL/min flow rate. The wavelength of detection was at 220nm. RESULT: The chromatographic retention times were consistent at 3.0, 10.5 and 13.8minutes for TSL, AML and GFN respectively. For these three compounds, the lower limit of detection was 1.0, 1.25, and 1.5µg/mL and lower limit of quantification was 3.3, 4.1 and 5.0µg/mL respectively. The linearity concentrations established for TSL, AML and GFN were 1.0-7.0, 1.5-7.5 and 4.0-14.0µg/mL respectively. The correlation coefficients for all the drugs were found to be greater than 0.999. The relative standard deviation of inter- and intra-day were less than 2.0%. CONCLUSION: This method provides a necessary tool for quantification of the selected drugs for their assay. The proposed method is simple, accurate, reproducible and applied successfully to analyze three compounds in pure as well dosage form.


Asunto(s)
Ambroxol/análisis , Broncodilatadores/análisis , Expectorantes/análisis , Guaifenesina/análisis , Terbutalina/análisis , Cromatografía de Fase Inversa , Formas de Dosificación , Combinación de Medicamentos , Límite de Detección , Reproducibilidad de los Resultados , Espectrofotometría Ultravioleta
5.
Luminescence ; 34(1): 77-83, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30536899

RESUMEN

Orciprenaline sulphate (ORP) is a direct-acting sympathomimetic with mainly beta-adrenoceptor stimulant activity. It is used as a bronchodilator in the management of reversible airway obstruction. For the first time, a rapid highly sensitive spectrofluorimetric method is described that is relied on measuring the fluorescence spectra of ORP at acidic pH and without addition of any chemical reagents. The relative fluorescence intensity was measured at 310 nm and after excitation at 224 nm. ORP native fluorescence was calibrated in both water and acetonitrile as diluting solvents. The method was designed to estimate the drug in miscellaneous matrices with high accuracy and precision. Linear ranges of calibration curves were 30.0-400.0 ng/ml and 10.0-240.0 ng/ml in water and acetonitrile, respectively. The detection limits were calculated and reached as low as 3.3 and 3.1 ng/ml, respectively, representing the ultra-sensitivity of the proposed method. This result permitted application of this method for spiked human plasma and urine and was used as a preliminary investigation with good percentage recovery (89.4-106.8%). The application was further extended to analyse ORP in its pharmaceutical formulations. The method was validated in compliance with International Council of Harmonization (ICH) Guidelines.


Asunto(s)
Metaproterenol/análisis , Espectrometría de Fluorescencia/métodos , Acetonitrilos/química , Broncodilatadores/análisis , Broncodilatadores/sangre , Broncodilatadores/orina , Calibración , Humanos , Concentración de Iones de Hidrógeno , Límite de Detección , Metaproterenol/sangre , Metaproterenol/orina , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Solventes/química
6.
Pulm Pharmacol Ther ; 51: 59-64, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29981458

RESUMEN

BACKGROUND: Poor adherence to inhaled drug therapy in individuals with asthma and/or chronic obstructive pulmonary disease (COPD) may be associated with suboptimal therapeutic outcomes. Measurement of drug residues in hair samples has been employed to assess oral medication use over time. Here, we test the feasibility of analyzing hair samples from patients with asthma and/or COPD for assessing adherence to prescribed inhaled medication. METHODS: In total, 200 male and female subjects, ≥ 18 years of age, with stable asthma and/or COPD who were receiving an acceptable standard of care daily inhaled product consistently, were recruited. Head hair samples were taken during a single visit to the clinical site and grouped by hair color according to the Fischer-Saller scale. Drug residues were extracted from milled hair samples using solid-phase extraction and analyzed using liquid chromatography-tandem mass spectrometry. RESULTS: Inhaled drugs were detected in hair for 72% of subjects from whom it was possible to analyze hair samples (n = 157/200). Most hair samples obtained from subjects receiving formoterol or vilanterol had amounts of drug present that allowed determination of a quantifiable concentration, and demonstrated a dose response. Drugs were detected in all hair colors, with higher concentrations of formoterol observed in dark-haired versus light-haired individuals. CONCLUSIONS: This is the first study to demonstrate that inhaled medication can be measured in hair samples from subjects with asthma and/or COPD. The results show that hair drug concentration data could potentially provide a record of historical adherence to inhaled therapeutics.


Asunto(s)
Asma/tratamiento farmacológico , Cabello/química , Cumplimiento de la Medicación , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Administración por Inhalación , Adolescente , Adulto , Anciano , Broncodilatadores/administración & dosificación , Broncodilatadores/análisis , Cromatografía Liquida/métodos , Femenino , Color del Cabello/fisiología , Humanos , Masculino , Persona de Mediana Edad , Espectrometría de Masas en Tándem/métodos , Adulto Joven
7.
Biosens Bioelectron ; 105: 36-41, 2018 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-29351868

RESUMEN

This paper reports an aptamer-based nanopore thin film sensor for detecting theophylline in the buffer solution and complex fluids including plant extracts and serum samples. Compared to antibody-based detection, aptamer-based detection offers many advantages such as low cost and high stability at elevated temperatures. Experiments found that this type of sensor can readily detect theophylline at a concentration as low as 0.05µM, which is much lower than the detection limit of current lab-based equipment such as liquid chromatography (LC). Experiments also found that the aptamer-based sensor has good specificity, selectivity, and reasonable reusability with a significantly improved dynamic detection range. By using the same nanopore thin film sensors as the reference sensors to further mitigate the non-specific binding effect, the theophylline in plant extracts and serum has been detected. Only a small amount (~1µL) of plant extracts or serum samples is required to measure theophylline. Its low cost and ease-of-operation make this type of sensor suitable for point-of-care application to monitor the theophylline level of patients in real time.


Asunto(s)
Aptámeros de Nucleótidos/química , Técnicas Biosensibles/instrumentación , Broncodilatadores/análisis , Nanoporos/ultraestructura , Teofilina/análisis , Vasodilatadores/análisis , Animales , Técnicas Biosensibles/métodos , Broncodilatadores/sangre , Cafeína/química , Bovinos , Diseño de Equipo , Límite de Detección , Extractos Vegetales/química , Teobromina/química , Teofilina/sangre , Vasodilatadores/sangre
8.
Anal Chim Acta ; 999: 54-59, 2018 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-29254574

RESUMEN

Theophylline is a common bronchodilator for the treatment of diseases like asthma, bronchitis and emphysema. However, it should be strictly used and monitored due to its toxicity when the concentration is above certain levels. In this work, an electrochemical biosensor for theophylline detection is proposed by recognition of RNA aptamer and gold nanoparticle (AuNP)-based amplification technique. First, RNA aptamer is splitted into two single-stranded RNA probes. One is hybridized with DNA tetrahedron and the resulted nanostructure is then immobilized onto a gold electrode; the other is modified on the surface of AuNPs which is also labeled with methylene blue (MB) as electrochemical species. The recognition process between the two RNA probes and theophylline causes the localization of AuNPs and the enrichment of MB on the electrode interface. A significant electrochemical response is thus generated which is related to the concentration of initial theophylline. This proposed aptasensor shows excellent sensitivity and selectivity which could also be applied in quantitatively detection of theophylline in serums samples.


Asunto(s)
Aptámeros de Nucleótidos/química , Técnicas Biosensibles/métodos , Broncodilatadores/sangre , Oro/química , Nanopartículas del Metal/química , Teofilina/sangre , Técnicas Biosensibles/instrumentación , Broncodilatadores/análisis , Técnicas Electroquímicas/instrumentación , Técnicas Electroquímicas/métodos , Electrodos , Humanos , Límite de Detección , Teofilina/análisis
9.
Biosens Bioelectron ; 101: 153-158, 2018 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-29065340

RESUMEN

Theophylline is a popular drug for many respiratory diseases. However, certain toxic side effects may be developed and the narrow safety range raises the demand for sensitive methods to constantly monitor theophylline levels. This study presents an electrochemical approach towards theophylline detection based on the recognition by split RNA aptamers. Target induced construction of hand-in-hand RNA nanowire on the electrode surface could further absorb silver nanoparticles (Ag NPs) as electrochemical species. When theophylline is not present, RNA probes are stable and their conformations remain unchanged. In contrast, theophylline is able to trigger the hairpin opening of RNA probe and subsequent self-assembly of RNA nanowire, which could be captured by DNA tetrahedron on the electrode interface. After further decorating Ag NPs on the nanowire, silver stripping current is measured to reveal initial theophylline concentration. The developed sensing strategy shows excellent specificity and sensitivity with the limit of detection of 50nM. Its practical utility is demonstrated by quantitative determination of theophylline levels in complex biological samples.


Asunto(s)
Aptámeros de Nucleótidos/química , Técnicas Biosensibles/métodos , Broncodilatadores/sangre , Nanocables/química , Teofilina/sangre , Adsorción , Broncodilatadores/análisis , Técnicas Electroquímicas/métodos , Humanos , Límite de Detección , Nanopartículas del Metal/química , Plata/química , Teofilina/análisis
10.
Curr Drug Discov Technol ; 15(4): 272-304, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-28875855

RESUMEN

BACKGROUND: Asthma is defined as a heterogeneous disease usually characterized by chronic airway inflammation (GINA 2016) affecting almost 334 million people worldwide (Global asthma report 2014). Treatment of asthma with a long-acting bronchodilator is important because it reduces the symptoms that occur at night or in the early morning and it is very effective to use as a long term control medication for asthma by preventing asthmatic symptoms. The main objective of this review is to describe the impurity profile and force degradation studies for three major classes of bronchodilators namely ß2-adrenoceptor agonists, muscarinic receptor antagonists and xanthine. Unidentified and potential toxic impurities are hazardous to health, so in order to increase the safety of drug therapy; impurities should be identified and determined by selective analytical methods. METHODS: Different conditions for degradations like hydrolytic (acidic, basic and neutral), oxidative, photolytic and thermolytic have been discussed in detail for bronchodilators. Furthermore, it is discussed with the name along with number of impurities and degradants present in different matrices including its clinical implication. The name as well as structures of all the observed impurities in different bronchodilators is included, which can aid in impurity profiling. Various analytical methods, including Chromatographic techniques like TLC; HPTLC; HPLC; GC, Spectroscopic techniques like UV; IR; NMR; MS and hyphenated techniques like GC-MS; LC-MS; CE-MS; SFC-MS; LC-NMR; CENMR; LC-FTIR has been used for the identification and quantification of impurities. A general scheme has been presented for the impurity profiling. RESULT: Nineteen articles, six patents and fifteen drugs are included in this review. In that, majority (7) of papers are based on HPLC-UV, 5 papers are based on LC-MS, 2 papers are based on LC-MS-NMR, 1 paper is based on LC-NMR, 1 paper is based on GC-MSNMR, 1 paper is based on GC-UV and 1 paper is based on TLC-UV technique for isolation and characterization of impurities. In salbutamol, 7 degradants were found by LC-MS as compare to 4 degradants by HPLC-UV. In bambuterol, 12 degradants were found by LC-MS-NMR as compare to 4 degradants by LC-MS. CONCLUSION: After a thorough literature search, LC-MS and LC-MS-NMR techniques are found most useful for impurity profiling. In future, LC-DAD-NMR-MS, CE-ESI-FTICR- MS can also be explored for the isolation and characterization of impurities.


Asunto(s)
Asma/tratamiento farmacológico , Broncodilatadores/análisis , Contaminación de Medicamentos/prevención & control , Química Farmacéutica/métodos , Cromatografía Líquida de Alta Presión/métodos , Humanos , Espectroscopía de Resonancia Magnética/métodos , Espectrometría de Masas/métodos
11.
AAPS PharmSciTech ; 18(8): 3296-3306, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28589305

RESUMEN

This article reports on results from a two-lab, multiple impactor experiment evaluating the abbreviated impactor measurement (AIM) concept, conducted by the Cascade Impaction Working Group of the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS). The goal of this experiment was to expand understanding of the performance of an AIM-type apparatus based on the Andersen eight-stage non-viable cascade impactor (ACI) for the assessment of inhalation aerosols and sprays, compared with the full-resolution version of that impactor described in the pharmacopeial compendia. The experiment was conducted at two centers with a representative commercially available pressurized metered dose inhaler (pMDI) containing albuterol (salbutamol) as active pharmaceutical ingredient (API). Metrics of interest were total mass (TM) emitted from the inhaler, impactor-sized mass (ISM), as well as the ratio of large particle mass (LPM) to small particle mass (SPM). ISM and the LPM/SPM ratio together comprise the efficient data analysis (EDA) metrics. The results of the comparison demonstrated that in this study, the AIM approach had adequate discrimination to detect changes in the mass median aerodynamic diameter (MMAD) of the ACI-sampled aerodynamic particle size distribution (APSD), and therefore could be employed for routine product quality control (QC). As with any test method considered for inclusion in a regulatory filing, the transition from an ACI (used in development) to an appropriate AIM/EDA methodology (used in QC) should be evaluated and supported by data on a product-by-product basis.


Asunto(s)
Albuterol/análisis , Inhaladores de Dosis Medida/normas , Tamaño de la Partícula , Tecnología Farmacéutica/métodos , Tecnología Farmacéutica/normas , Administración por Inhalación , Aerosoles , Albuterol/química , Broncodilatadores/análisis , Broncodilatadores/química , Diseño de Equipo/métodos , Diseño de Equipo/normas , Inhaladores de Dosis Medida/tendencias , Nebulizadores y Vaporizadores/normas , Nebulizadores y Vaporizadores/tendencias , Control de Calidad
12.
Biomed Chromatogr ; 31(11)2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28431453

RESUMEN

Herein we present the enantioseparation of 10 cardiovascular agents and six bronchiectasis drugs including propranolol, carteolol, metoprolol, atenolol, pindolol, esmolol, bisoprolol, bevantolol, arotinolol, sotalol, clenbuterol, procaterol, bambuterol, tranterol, salbutamol and terbutaline sulfate using carboxymethyl-ß-cyclodextrin (CM-ß-CD) as chiral selector. To our knowledge, there is no literature about using CM-ß-CD for separating carteolol, esmolol, bisoprolol, bevantolol, arotinolol, procaterol, bambuterol and tranterol. During the course of work, changes in pH, CM-ß-CD concentration, buffer type and concentration were studied in relation to chiral resolution. Excellent enantiomeric separations were obtained for all 16 compounds, especially for procaterol. An impressive resolution value, up to 17.10, was obtained. In particular, most of them achieved rapid separations within 20 min. Given the fact that enantioseparation results rely on analytes' structural characters, the possible separation mechanisms were discussed. In addition, in order to obtain faster separation for propranolol enantiomers in practical application, the effective length of capillary was innovatively shortened from 45 to 30 cm. After the validation, the method was successfully applied to the enantiomeric purity determination of propranolol in the formulation of drug substances.


Asunto(s)
Electroforesis Capilar/métodos , Propanolaminas/química , Propanolaminas/aislamiento & purificación , beta-Ciclodextrinas/química , Broncodilatadores/análisis , Broncodilatadores/química , Broncodilatadores/aislamiento & purificación , Fármacos Cardiovasculares/análisis , Fármacos Cardiovasculares/química , Fármacos Cardiovasculares/aislamiento & purificación , Límite de Detección , Modelos Lineales , Propanolaminas/análisis , Reproducibilidad de los Resultados , Estereoisomerismo
13.
Biosens Bioelectron ; 91: 804-810, 2017 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-28152486

RESUMEN

Two unique immunosensors made of aluminum-based metal-organic frameworks (MOFs), namely, 515- and 516-MOFs, with 4,4',4''-nitrilotribenzoic acid (H3NTB) were successfully obtained to efficiently assess food safety. The as-prepared 515- and 516-MOFs exhibited superior thermal and physicochemical stability, high electrochemical activity, and good biocompatibility. Among these immunosensors, 516-MOF showed a preferable biosensing ability toward analytes determined by electrochemical techniques. The developed 516-MOF-based electrochemical biosensor not only demonstrated high sensitivity with low detection limits of 0.70 and 0.40pgmL-1 toward vomitoxin and salbutamol, respectively, but also showed good selectivity in the presence of other interferences. Therefore, with the advantages of high sensitivity, good selectivity, and simple operation, this new strategy is believed to exhibit great potential for simple and convenient detection of poisonous and harmful residues in food.


Asunto(s)
Aluminio/química , Técnicas Electroquímicas/métodos , Análisis de los Alimentos/métodos , Contaminación de Alimentos/análisis , Compuestos Organometálicos/química , Albuterol/análisis , Animales , Anticuerpos Inmovilizados/química , Técnicas Biosensibles/métodos , Broncodilatadores/análisis , Límite de Detección , Modelos Moleculares , Carne Roja/análisis , Porcinos , Tricotecenos/análisis , Vino/análisis
14.
Drug Test Anal ; 9(8): 1262-1266, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28033454

RESUMEN

Salmeterol (USAN, INN, BAN) is a long-acting beta2-adrenoceptor agonist (LABA) widely used in the treatment of airways disease. Although salmeterol is permitted via inhalation by athletes and supratherapeutic dosing may enhance performance, no urine threshold has been established by the World Anti-Doping Agency (WADA). Salmeterol is a chiral compound consisting of (R)- and (S)-enantiomers, normally administered as racemic (rac-) mixture via inhalation. Levels of rac-salmeterol in urine are often below detectable levels and there is surprisingly little information regarding the enantioselectivity of salmeterol pharmacokinetics. In this study, subjects inhaled either 50 (n = 6) or 200 µg (n = 4; generally regarded as maximum therapeutic dose) of salmeterol and urine was then collected for 24 h and analyzed by enantioselective ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Maximum rac-salmeterol urine concentrations were obtained at 2 h for both doses with medians of 0.084 ng/mL after the 50 µg dose and 2.1 ng/mL after the 200 µg dose, with an individual maximum of 5.7 ng/mL. Levels were detectable at 24 h for both doses. Salmeterol displayed enantioselective pharmacokinetics, with a mean ± SD log (S):(R) = 0.055 ± 0.025 (P < 0.0001) equivalent to (S):(R) of 1.13. In conclusion, rac-salmeterol by inhalation exhibits modest enantioselectivity in urine following single dose administration and can be detected following a single 50 µg dose for up to 24 h after inhalation. The present findings are of relevance if a urine threshold limit is to be introduced for salmeterol on the list of prohibited substances. The application of an enantiomer ratio analysis may offer improved discriminatory detection capability for doping control analysis applications. Copyright © 2016 John Wiley & Sons, Ltd.


Asunto(s)
Agonistas de Receptores Adrenérgicos beta 2/orina , Broncodilatadores/orina , Xinafoato de Salmeterol/orina , Espectrometría de Masas en Tándem/métodos , Administración por Inhalación , Agonistas de Receptores Adrenérgicos beta 2/administración & dosificación , Agonistas de Receptores Adrenérgicos beta 2/análisis , Broncodilatadores/administración & dosificación , Broncodilatadores/análisis , Cromatografía Líquida de Alta Presión/métodos , Doping en los Deportes , Femenino , Humanos , Masculino , Xinafoato de Salmeterol/administración & dosificación , Xinafoato de Salmeterol/análisis , Estereoisomerismo , Detección de Abuso de Sustancias/métodos
15.
Pharm Res ; 33(10): 2470-80, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27324960

RESUMEN

PURPOSE: To characterize the distribution of water among various components in a powder blend using solid-state NMR spectroscopy. METHODS: Water sorption behavior of theophylline anhydrate and excipients was determined by dynamic vapor sorption (DVS) and Karl Fischer Titration (KFT) after storing them in humidity chambers for 1 week at room temperature (RT) and calibration curves were generated for water content vs. (1)H T 1 relaxation times. Powder blends (either with microcrystalline cellulose or lactose as diluent) were stored at different relative humidity (RH) conditions and analyzed periodically using solid-state NMR, powder X-ray diffraction, and KFT. RESULTS: Anhydrous theophylline converted to the hydrate at ≥ 84% RH. Based on the calibration curves of water content vs. relaxation times, the distribution of water in the powder blends was estimated. The total water content calculated using ssNMR was in good agreement with values measured using KFT. In blends stored at 90% RH, theophylline anhydrate-to-hydrate conversion did not occur in 1 week. CONCLUSIONS: The distribution of water in multi-component powder blends was successfully determined using correlation between (1)H T 1 relaxation times and total water content. Excipient water sorption inhibited hydrate formation in theophylline at 90% RH. Water distribution was affected by excipient type. The extent of water sorbed by excipients in blends was found to be different than their standalone equilibrium water content.


Asunto(s)
Excipientes/metabolismo , Espectroscopía de Resonancia Magnética/métodos , Teofilina/metabolismo , Agua/metabolismo , Broncodilatadores/análisis , Broncodilatadores/metabolismo , Excipientes/análisis , Teofilina/análisis , Agua/análisis , Difracción de Rayos X/métodos
16.
Biosens Bioelectron ; 85: 337-342, 2016 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-27183285

RESUMEN

In this study, the three nanomaterials: colloidal gold, nanogold-polyaniline-nanogold microspheres (GPGs) and colloidal carbon were respectively labeled with the antibody against salbutamol (SAL). We aimed to develop immunochromatographic strips with these nanomaterial labels and determine their performance in visual detection of SAL. For the colloidal gold-based strip, the detection limit of SAL was 1.0µgL(-1) in standard solution and 5.0µgkg(-1) in meat samples. For the GPG- and colloidal carbon-based strips, the limit of detection was 2.0µgL(-1) in standard solution and 10µgkg(-1) in meat samples. The results obtained using the test strips were found to be highly consistent with those obtained using a commercial kit, indicating the high accuracy of these strips. The three strips were also found to be stable up to 18 weeks under laboratory conditions. In terms of sensitivity, the colloidal gold-based strip was slightly better than the other two. For the GPG- and colloidal carbon-based strips, the difference between the results obtained for different batches was small (high consistency), and the stability was much better than that of the colloidal gold-based one. Our results indicate that colloidal carbon can be used as a label in immunochromatographic tests; it can also help reduce the cost involved and scale-up the production. The use of immunochromatographic test strips labeled with colloidal carbon can be a rapid and inexpensive method for SAL assays in on-site applications.


Asunto(s)
Albuterol/análisis , Compuestos de Anilina/química , Broncodilatadores/análisis , Carbono/química , Cromatografía de Afinidad/instrumentación , Oro Coloide/química , Carne/análisis , Tiras Reactivas/análisis , Animales , Anticuerpos Monoclonales/química , Técnicas Biosensibles/instrumentación , Bovinos , Coloides/química , Diseño de Equipo , Análisis de los Alimentos/instrumentación , Límite de Detección , Carne Roja/análisis , Ovinos , Porcinos
17.
Respir Care ; 60(10): 1424-30, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25969513

RESUMEN

BACKGROUND: Optimization of factors affecting aerosol delivery during mechanical ventilation in the pediatric population is important. We hypothesized that increasing the tidal volume (V(T)), using a vibrating mesh nebulizer, and placing the nebulizer at the ventilator would increase lung dose/delivery efficiency. METHODS: Continuous-output jet and vibrating mesh nebulizers loaded with albuterol (2.5 mg/3 mL) were compared when placed before the Y-piece and at the ventilator. The model consisted of a ventilator operated in pressure-regulated volume control ventilation mode at a breathing frequency of 20 breaths/min, PEEP of 5 cm H2O, FIO2 of 0.4, inspiratory time of 0.75 s, and bias flow of 0.5 L/min with a humidifier (37 ± 1.5°C) and an adult heated-wired circuit. V(T) values of 100, 150, 200, and 300 mL were studied. The circuit was connected in series to a 5.5-mm inner diameter endotracheal tube with a filter (lung dose) interposed between them. Delivery efficiency was calculated as a percentage of the nominal dose captured on the filter. Albuterol content was analyzed by spectrophotometry (276 nm). RESULTS: No differences in lung dose/delivery efficiency were found at different V(T) values for the jet nebulizer (both positions) and the vibrating mesh nebulizer (ventilator). Lung dose/delivery efficiency was higher (P < .02) at a VT of 100 mL compared with the other volumes tested. The vibrating mesh nebulizer had higher lung dose/delivery efficiency compared with the jet nebulizer only when placed before the Y-piece. Moving the nebulizers from before the Y-piece to the ventilator increased lung dose/delivery efficiency for all conditions tested except the vibrating mesh nebulizer at a V(T) of 100 mL (P = .36). CONCLUSIONS: Optimization of inhaled drug delivery during pediatric mechanical ventilation should include careful selection of the type of delivery device and its placement in the ventilator circuit. Increasing V(T) during nebulization did not increase lung dose/delivery efficiency.


Asunto(s)
Albuterol/administración & dosificación , Broncodilatadores/administración & dosificación , Sistemas de Liberación de Medicamentos/instrumentación , Nebulizadores y Vaporizadores , Respiración Artificial/instrumentación , Volumen de Ventilación Pulmonar/efectos de los fármacos , Administración por Inhalación , Albuterol/análisis , Broncodilatadores/análisis , Niño , Sistemas de Liberación de Medicamentos/métodos , Diseño de Equipo , Humanos , Intubación Intratraqueal/instrumentación , Modelos Teóricos , Pediatría/instrumentación , Respiración Artificial/métodos , Frecuencia Respiratoria , Ventiladores Mecánicos
18.
Int J Pharm ; 489(1-2): 11-7, 2015 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-25891255

RESUMEN

The use of single particle aerosol mass spectrometry (SPAMS) was evaluated for the analysis of inhaled pharmaceuticals to determine the mass distribution of the individual active pharmaceutical ingredients (API) in both single ingredient and combination drug products. SPAMS is an analytical technique where the individual aerodynamic diameters and chemical compositions of many aerosol particles are determined in real-time. The analysis was performed using a Livermore Instruments SPAMS 3.0, which allowed the efficient analysis of aerosol particles with broad size distributions and can acquire data even under a very large particle load. Data similar to what would normally require roughly three days of experimentation and analysis was collected in a five minute period and analyzed automatically. The results were computed to be comparable to those returned by a typical Next Generation Impactor (NGI) particle size distribution experiment.


Asunto(s)
Aerosoles/análisis , Espectrometría de Masas/métodos , Inhaladores de Dosis Medida , Albuterol/análisis , Combinación Albuterol y Ipratropio , Broncodilatadores/análisis , Fluticasona/análisis , Combinación Fluticasona-Salmeterol , Ipratropio/análisis , Sistemas en Línea , Tamaño de la Partícula , Xinafoato de Salmeterol/análisis
20.
Drug Metab Lett ; 8(1): 31-5, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25313021

RESUMEN

In the present study, two new methods were developed for the quantitative determination of active components of Seretide(®), commercially available pharmaceutical preparation in the diskus form. One of these methods was based on derivative spectrophotometry and used a zero-crossing technique. The determinations of fluticasone propionate and salmeterol xinafoate were performed by first order derivatisation at 216.5 nm and second order derivatisation at 250 nm, respectively. The concentration ranges were 5.0-32.5 µg/mL for fluticasone propionate and 2-12 µg/mL for salmeterol xinafoate. The second method developed also included high performance liquid chromatography. In this method, a methanol-water mobile phase mixture (95:5, v/v) and a C18 chromasil column as a stationary phase were used. The wavelength of the diode array UV detector was 260 nm; the flow rate was 1 mL/min. The concentration ranges were 2-16 µg/mL for fluticasone propionate and 1-8 µg/mL for salmeterol xinafoate. The results for both methods from diskus are in the pharmacopea limits. For the statistical determination of these results, these two methods were compared with t-test for the means and with F-test for the standard deviations.


Asunto(s)
Agonistas de Receptores Adrenérgicos beta 2/análisis , Albuterol/análogos & derivados , Androstadienos/análisis , Antiasmáticos/análisis , Broncodilatadores/análisis , Cromatografía Líquida de Alta Presión , Inhaladores de Polvo Seco , Espectrofotometría Ultravioleta , Administración por Inhalación , Agonistas de Receptores Adrenérgicos beta 2/administración & dosificación , Albuterol/administración & dosificación , Albuterol/análisis , Androstadienos/administración & dosificación , Antiasmáticos/administración & dosificación , Broncodilatadores/administración & dosificación , Calibración , Cromatografía Líquida de Alta Presión/normas , Combinación de Medicamentos , Fluticasona , Combinación Fluticasona-Salmeterol , Límite de Detección , Modelos Lineales , Estándares de Referencia , Reproducibilidad de los Resultados , Xinafoato de Salmeterol , Espectrofotometría Ultravioleta/normas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA